224 filings
8-K
COLL
Collegium Pharmaceutical Inc
13 Jun 24
Other Events
8:05am
8-K
COLL
Collegium Pharmaceutical Inc
24 May 24
Departure of Directors or Certain Officers
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
20 May 24
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
COLL
Collegium Pharmaceutical Inc
13 May 24
Other Events
8:05am
DEFA14A
COLL
Collegium Pharmaceutical Inc
10 May 24
Additional proxy soliciting materials
8:03am
8-K
p51pmj3
10 May 24
Departure of Directors or Certain Officers
8:02am
8-K
j2ppfzn9k98s
9 May 24
Collegium Reports First Quarter 2024 Financial Results
4:04pm
8-K
il0gg aqoqhcs
29 Apr 24
Entry into a Material Definitive Agreement
8:05am
8-K
r9cz8 hv80t
11 Apr 24
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
8:00am
ARS
79d0bdmu
5 Apr 24
Annual report to shareholders
4:03pm
DEFA14A
puwn2o5p7u96
5 Apr 24
Additional proxy soliciting materials
4:03pm
8-K
ldpaw9rl0qldhcpq
22 Feb 24
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
4:01pm
8-K
0qg ghitfj
3 Jan 24
Regulation FD Disclosure
8:03am
8-K
6r0ookg49y0vfpjd0r
9 Nov 23
Other Events
8:05am
8-K
l2ie v3sipiy1mgsr4v
7 Nov 23
Collegium Reports Third Quarter 2023 Financial Results
4:01pm
8-K
v4qvou u626
24 Aug 23
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
8:05am